腎臓/腎線維症治療の世界市場 2022年-2026年

【英語タイトル】Global Kidney/Renal Fibrosis Treatment Market Research Report 2022-2026

9Dimen Researchが出版した調査資料(DMN22OT2300)・商品コード:DMN22OT2300
・発行会社(調査会社):9Dimen Research
・発行日:2022年10月(※2025年版があります。お問い合わせください。)
・ページ数:152
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル、北アメリカ、ヨーロッパ、アジア太平洋
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,200 ⇒換算¥480,000見積依頼/購入/質問フォーム
Global/Corporate User(法人閲覧用)USD5,800 ⇒換算¥870,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

米中貿易戦争、世界経済の不安定性と不確実性は世界の腎臓/腎線維症治療市場に大きな影響を与えるでしょう。腎臓/腎線維症治療市場資料は、主要地域(北アメリカ、ヨーロッパ、アジア太平洋)と主要国(アメリカ、ドイツ、英国、日本、韓国、中国)に焦点を当てた、世界の主要地域の市場状況に関する専門的かつ包括的な調査資料です。この資料では、世界の腎臓/腎線維症治療市場規模は 2022年にXX百万ドルと評価され、2026年末までにXX百万ドルに達すると予測されており、2022年から2026年にかけてXX%のCAGRで成長すると予測されています。
本調査資料に記載されている主要な企業は、Galectin Therapeutics、Merck & Co.、F. Hoffman-La Roche Ltd.、Pfizer Inc.、InterMune Inc.、ProMetic Life-Sciences Inc.、La Jolla Pharmaceutical Company、Genzyme Corporation、BioLine Rx Ltd、……などです。

本資料は、世界の腎臓/腎線維症治療市場(2022年-2026年)について調査・分析し、腎臓/腎線維症治療の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別(アンジオテンシンII受容体拮抗薬(ARB)、アンジオテンシン変換酵素(ACE)阻害薬、ピルフェニドン、レニン阻害薬、バソペプチダーゼ阻害薬、……など)、用途別(商業/私立病院、公立病院、診療所、在宅治療、……など)のセグメント情報も収録しています。

・腎臓/腎線維症治療の市場概要
・腎臓/腎線維症治療の上流・下流市場分析
・腎臓/腎線維症治療のアジア市場:市場分析(製品開発、競争環境、市場動向等)
・腎臓/腎線維症治療のアジア市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・腎臓/腎線維症治療のアジア市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・腎臓/腎線維症治療のアジア市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・腎臓/腎線維症治療の北アメリカ市場:市場分析(製品開発、競争環境、市場動向等)
・腎臓/腎線維症治療の北アメリカ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・腎臓/腎線維症治療の北アメリカ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・腎臓/腎線維症治療の北アメリカ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・腎臓/腎線維症治療のヨーロッパ市場:市場分析(製品開発、競争環境、市場動向等)
・腎臓/腎線維症治療のヨーロッパ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・腎臓/腎線維症治療のヨーロッパ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・腎臓/腎線維症治療のヨーロッパ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・腎臓/腎線維症治療のマーケティングチャネル分析
・マクロ経済分析(中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済)
・腎臓/腎線維症治療の投資可能性分析
・腎臓/腎線維症治療の世界市場規模(2017年-2022年推移、2022年-2026年予測)
...

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Kidney/Renal Fibrosis Treatment Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Kidney/Renal Fibrosis Treatment market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Kidney/Renal Fibrosis Treatment basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Galectin Therapeutics
Merck & Co.
F. Hoffman-La Roche Ltd.
Pfizer Inc.
InterMune Inc.
ProMetic Life-Sciences Inc.
La Jolla Pharmaceutical Company
Genzyme Corporation
BioLine Rx Ltd
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Angiotensin II Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Kidney/Renal Fibrosis Treatment for each application, including-
Commercial/Private Hospitals
Public Health Hospitals
Clinics
Home Treatment
……

❖ レポートの目次 ❖

Table of Contents

Part I Kidney/Renal Fibrosis Treatment Industry Overview

Chapter One Kidney/Renal Fibrosis Treatment Industry Overview
1.1 Kidney/Renal Fibrosis Treatment Definition
1.2 Kidney/Renal Fibrosis Treatment Classification Analysis
1.2.1 Kidney/Renal Fibrosis Treatment Main Classification Analysis
1.2.2 Kidney/Renal Fibrosis Treatment Main Classification Share Analysis
1.3 Kidney/Renal Fibrosis Treatment Application Analysis
1.3.1 Kidney/Renal Fibrosis Treatment Main Application Analysis
1.3.2 Kidney/Renal Fibrosis Treatment Main Application Share Analysis
1.4 Kidney/Renal Fibrosis Treatment Industry Chain Structure Analysis
1.5 Kidney/Renal Fibrosis Treatment Industry Development Overview
1.5.1 Kidney/Renal Fibrosis Treatment Product History Development Overview
1.5.1 Kidney/Renal Fibrosis Treatment Product Market Development Overview
1.6 Kidney/Renal Fibrosis Treatment Global Market Comparison Analysis
1.6.1 Kidney/Renal Fibrosis Treatment Global Import Market Analysis
1.6.2 Kidney/Renal Fibrosis Treatment Global Export Market Analysis
1.6.3 Kidney/Renal Fibrosis Treatment Global Main Region Market Analysis
1.6.4 Kidney/Renal Fibrosis Treatment Global Market Comparison Analysis
1.6.5 Kidney/Renal Fibrosis Treatment Global Market Development Trend Analysis

Chapter Two Kidney/Renal Fibrosis Treatment Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Kidney/Renal Fibrosis Treatment Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Kidney/Renal Fibrosis Treatment Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Kidney/Renal Fibrosis Treatment Market Analysis
3.1 Asia Kidney/Renal Fibrosis Treatment Product Development History
3.2 Asia Kidney/Renal Fibrosis Treatment Competitive Landscape Analysis
3.3 Asia Kidney/Renal Fibrosis Treatment Market Development Trend

Chapter Four 2017-2022 Asia Kidney/Renal Fibrosis Treatment Productions Supply Sales Demand Market Status and Forecast
4.1 2017-2022 Kidney/Renal Fibrosis Treatment Production Overview
4.2 2017-2022 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
4.3 2017-2022 Kidney/Renal Fibrosis Treatment Demand Overview
4.4 2017-2022 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
4.5 2017-2022 Kidney/Renal Fibrosis Treatment Import Export Consumption
4.6 2017-2022 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Chapter Five Asia Kidney/Renal Fibrosis Treatment Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Kidney/Renal Fibrosis Treatment Industry Development Trend
6.1 2022-2026 Kidney/Renal Fibrosis Treatment Production Overview
6.2 2022-2026 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
6.3 2022-2026 Kidney/Renal Fibrosis Treatment Demand Overview
6.4 2022-2026 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
6.5 2022-2026 Kidney/Renal Fibrosis Treatment Import Export Consumption
6.6 2022-2026 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Part III North American Kidney/Renal Fibrosis Treatment Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Kidney/Renal Fibrosis Treatment Market Analysis
7.1 North American Kidney/Renal Fibrosis Treatment Product Development History
7.2 North American Kidney/Renal Fibrosis Treatment Competitive Landscape Analysis
7.3 North American Kidney/Renal Fibrosis Treatment Market Development Trend

Chapter Eight 2017-2022 North American Kidney/Renal Fibrosis Treatment Productions Supply Sales Demand Market Status and Forecast
8.1 2017-2022 Kidney/Renal Fibrosis Treatment Production Overview
8.2 2017-2022 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
8.3 2017-2022 Kidney/Renal Fibrosis Treatment Demand Overview
8.4 2017-2022 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
8.5 2017-2022 Kidney/Renal Fibrosis Treatment Import Export Consumption
8.6 2017-2022 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Chapter Nine North American Kidney/Renal Fibrosis Treatment Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Kidney/Renal Fibrosis Treatment Industry Development Trend
10.1 2022-2026 Kidney/Renal Fibrosis Treatment Production Overview
10.2 2022-2026 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
10.3 2022-2026 Kidney/Renal Fibrosis Treatment Demand Overview
10.4 2022-2026 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
10.5 2022-2026 Kidney/Renal Fibrosis Treatment Import Export Consumption
10.6 2022-2026 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Part IV Europe Kidney/Renal Fibrosis Treatment Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Kidney/Renal Fibrosis Treatment Market Analysis
11.1 Europe Kidney/Renal Fibrosis Treatment Product Development History
11.2 Europe Kidney/Renal Fibrosis Treatment Competitive Landscape Analysis
11.3 Europe Kidney/Renal Fibrosis Treatment Market Development Trend

Chapter Twelve 2017-2022 Europe Kidney/Renal Fibrosis Treatment Productions Supply Sales Demand Market Status and Forecast
12.1 2017-2022 Kidney/Renal Fibrosis Treatment Production Overview
12.2 2017-2022 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
12.3 2017-2022 Kidney/Renal Fibrosis Treatment Demand Overview
12.4 2017-2022 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
12.5 2017-2022 Kidney/Renal Fibrosis Treatment Import Export Consumption
12.6 2017-2022 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Chapter Thirteen Europe Kidney/Renal Fibrosis Treatment Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Kidney/Renal Fibrosis Treatment Industry Development Trend
14.1 2022-2026 Kidney/Renal Fibrosis Treatment Production Overview
14.2 2022-2026 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
14.3 2022-2026 Kidney/Renal Fibrosis Treatment Demand Overview
14.4 2022-2026 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
14.5 2022-2026 Kidney/Renal Fibrosis Treatment Import Export Consumption
14.6 2022-2026 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Part V Kidney/Renal Fibrosis Treatment Marketing Channels and Investment Feasibility

Chapter Fifteen Kidney/Renal Fibrosis Treatment Marketing Channels Development Proposals Analysis
15.1 Kidney/Renal Fibrosis Treatment Marketing Channels Status
15.2 Kidney/Renal Fibrosis Treatment Marketing Channels Characteristic
15.3 Kidney/Renal Fibrosis Treatment Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Kidney/Renal Fibrosis Treatment New Project Investment Feasibility Analysis
17.1 Kidney/Renal Fibrosis Treatment Market Analysis
17.2 Kidney/Renal Fibrosis Treatment Project SWOT Analysis
17.3 Kidney/Renal Fibrosis Treatment New Project Investment Feasibility Analysis

Part VI Global Kidney/Renal Fibrosis Treatment Industry Conclusions

Chapter Eighteen 2017-2022 Global Kidney/Renal Fibrosis Treatment Productions Supply Sales Demand Market Status and Forecast
18.1 2017-2022 Kidney/Renal Fibrosis Treatment Production Overview
18.2 2017-2022 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
18.3 2017-2022 Kidney/Renal Fibrosis Treatment Demand Overview
18.4 2017-2022 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
18.5 2017-2022 Kidney/Renal Fibrosis Treatment Import Export Consumption
18.6 2017-2022 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Chapter Nineteen Global Kidney/Renal Fibrosis Treatment Industry Development Trend
19.1 2022-2026 Kidney/Renal Fibrosis Treatment Production Overview
19.2 2022-2026 Kidney/Renal Fibrosis Treatment Production Market Share Analysis
19.3 2022-2026 Kidney/Renal Fibrosis Treatment Demand Overview
19.4 2022-2026 Kidney/Renal Fibrosis Treatment Supply Demand and Shortage
19.5 2022-2026 Kidney/Renal Fibrosis Treatment Import Export Consumption
19.6 2022-2026 Kidney/Renal Fibrosis Treatment Cost Price Production Value Gross Margin

Chapter Twenty Global Kidney/Renal Fibrosis Treatment Industry Research Conclusions



★調査レポート[腎臓/腎線維症治療の世界市場 2022年-2026年] (コード:DMN22OT2300)販売に関する免責事項を必ずご確認ください。
★調査レポート[腎臓/腎線維症治療の世界市場 2022年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆